Results 131 to 140 of about 97,685,983 (158)
Citrullination and Deamidation in Type 1 Diabetes: Linking Beta Cell Stress to Neoantigen-Driven Autoimmunity. [PDF]
Callebaut A +4 more
europepmc +1 more source
Cellular Consequences, Citrullination Substrates, and Antigenicity of Targeting PAD4 to Cell Surfaces. [PDF]
Kong S +5 more
europepmc +1 more source
High-quality draft genome of the Listeria monocytogenes, one more vaccine strain against livestock listeriosis. [PDF]
Feodorova VA +4 more
europepmc +1 more source
Pathogenicity of <i>P. gingivalis</i> strains carrying clusters of specific polymorphic variants of peptidylarginine deiminase gene. [PDF]
Strzelec K +17 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
International Journal of Rheumatic Diseases, 2022
AbstractAimRheumatoid arthritis (RA) is an autoimmune disease which affects millions of lives globally characterized by chronic inflammation in the joints of the body. There is no known cause for RA; however, genetic predisposition has been associated with its occurrence.
Samuel Asamoah Sakyi +7 more
openaire +2 more sources
AbstractAimRheumatoid arthritis (RA) is an autoimmune disease which affects millions of lives globally characterized by chronic inflammation in the joints of the body. There is no known cause for RA; however, genetic predisposition has been associated with its occurrence.
Samuel Asamoah Sakyi +7 more
openaire +2 more sources
Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor [PDF]
Protein arginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes the conversion of arginine to citrulline within target proteins. Dysregulation of PAD4 has been implicated in a number of human diseases, including rheumatoid arthritis and ...
Jonathan A. Ellman +2 more
exaly +2 more sources
Novel Furan-Containing Peptide-Based Inhibitors of Protein Arginine Deiminase Type IV (PAD4) [PDF]
Protein arginine deiminase type IV (PAD4) is responsible for the posttranslational conversion of peptidylarginine to peptidylcitrulline. Citrullinated protein is the autoantigen in rheumatoid arthritis, and therefore, PAD4 is currently a promising ...
Bimo Ario Tejo +2 more
exaly +2 more sources

